Tumorigenic properties of alternative osteopontin isoforms in mesothelioma

Biochem Biophys Res Commun. 2009 May 8;382(3):514-8. doi: 10.1016/j.bbrc.2009.03.042. Epub 2009 Mar 13.

Abstract

Osteopontin (SPP1) is an inflammatory cytokine that we previously characterized as a diagnostic marker in patients with asbestos-induced malignant mesothelioma (MM). While SPP1 shows both pro- and anti-tumorigenic biological effects, little is known about the molecular basis of these activities. In this study, we demonstrate that while healthy pleura possesses all three differentially spliced SPP1 isoforms (A-C), in clinical MM specimens isoform A is markedly up-regulated and predominant. To provide a clue to possible functions of the SPP1 isoforms we next performed their functional evaluation via transient expression in MM cell lines. As a result, we report that isoforms A-C demonstrate different activities in cell proliferation, wound closure, and invasion assays. These findings suggest different functions for SPP1 isoforms and underline pro-tumorigenic properties of isoforms A and B.

MeSH terms

  • Alternative Splicing
  • Amino Acid Sequence
  • Cell Line, Tumor
  • Cell Transformation, Neoplastic / genetics
  • Cell Transformation, Neoplastic / metabolism*
  • Humans
  • Mesothelioma / metabolism*
  • Mesothelioma / pathology
  • Molecular Sequence Data
  • Osteopontin / genetics
  • Osteopontin / physiology*
  • Pleura / metabolism
  • Pleura / pathology
  • Protein Isoforms / genetics
  • Protein Isoforms / physiology
  • RNA, Messenger / metabolism
  • Solitary Fibrous Tumor, Pleural / metabolism*
  • Solitary Fibrous Tumor, Pleural / pathology
  • Up-Regulation

Substances

  • Protein Isoforms
  • RNA, Messenger
  • Osteopontin